Skip to main content
. 2016 May 30;5(5):e229. doi: 10.1038/oncsis.2016.22

Figure 8.

Figure 8

ERO1L and G3BP2 may be target genes of ANCCA/PRO2000. (a) qRT–PCR and western blotting validated significant upregulation of ERO1L and G3BP2 expression in siANCCA-treated cells. Data represent mean±s.d. of three independent experiments. (b) The association between ANCCA and ERO1L or between ANCCA and G3BP2 was analyzed by co-immunoprecipitation in HepG2 cell. *P<0.05; **P<0.01, versus siCtrl.